Skip to main content
. 2024 Dec 9;52:102198. doi: 10.1016/j.tranon.2024.102198

Fig. 3.

Fig. 3

Relationship between perioperative change of circulating lymphocyte subsets with varying immunophenotypes and recurrence-free survival (RFS)/progression‐free survival (PFS) in the stage II/IV group and high-risk group. (A) RFS/PFS for postoperative increments of percentage of CD56dim NK cell on POD30 in stage III/IV group. (B) RFS/PFS for postoperative increments of percentage of CD56+ NK cell on POD30 in stage III/IV group. (C) RFS/PFS for postoperative increments of percentage of CD56dim NK cell on POD30 in preoperative high-risk group (D) RFS/PFS for postoperative increments of percentage of CD56+ NK cell on POD30 in preoperative high-risk group.